NCT05296369

Folic Acid Interferes With Radiation Esophagitis

Randomized Controlled Clinical Study of Folic Acid Treatment of Radiation Esophagitis After Chemoradiation in Lung Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: Guizhou Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This randomized study compared the incidence and severity of radiation esophagitis with folic acid and with conventional symptomatic treatment.

Detailed description

By prospective randomized controlled study, this study research plans to recruit with diagnosis of lung cancer patients, according to whether there is drug intervention were divided into treatment group and control group, compared two groups of acute radiation esophagitis in the before and after the intervention, extent of occurrence of folic acid and clinical curative effect, so as to verify whether folic acid can be used as an intervention in the treatment of radioactive esophagitis, To explore the safety of folic acid in the treatment of radioactive esophagitis and explore the standardized treatment of radioactive esophagitis.

Conditions

• Lung Cancer

Interventions

Type	Name	Description
DRUG	Folic acid	Folic acid was added during the period prior to concurrent chemoradiotherapy

Timeline

• Start date: 2022-03-01
• Primary completion: 2023-05-01
• Completion: 2023-05-01
• First posted: 2022-03-25
• Last updated: 2022-03-25

Locations

1 site across 1 country: China